Amir Mehrkar
Director of Information Governance and External Relations
Amir is a general practitioner with over 10 years of experience in senior leadership roles in health technology. This includes: interim Chief Medical Officer of NHS Digital, where Amir wrote the organisation’s clinical informatics governance framework; CCIO of Orion Health (EMEA) and CCIO of one of the UK’s biggest shared care records; co-founder of a free educational event (INTEROPSUMMIT), and INTEROPen, the UK’s first interoperability community, with over 300 supplier and NHS organisations as members, where Amir led the creation of the UK’s first interoperability data standards in FHIR.
Papers by Amir Mehrkar
- Consistency, completeness and external validity of ethnicity recording in NHS primary care records: a cohort study in 25 million patients’ records at source using OpenSAFELY
- Changes in sick notes associated with COVID-19 from 2020 to 2022: a cohort study in 24 million primary care patients in OpenSAFELY-TPP
- Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England
- Changes in opioid prescribing during the COVID-19 pandemic in England
- Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak
- OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents
- Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults
- Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations
- The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism
- Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)
- Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data
- The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate
- The impact of COVID-19 on medication reviews in English primary care
- Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England
- Impact of vaccination on the association of COVID-19 with cardiovascular diseases
- During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in England
- The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19
- Measuring BMI in 22 million patients in England
- Weight trends amongst adults with diabetes or hypertension during the COVID-19 pandemic
- Safety of direct-acting oral anticoagulant (DOAC) prescribing
- OpenSAFELY: a platform for analysing electronic health records designed for reproducible research
- Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic
- Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease
- Impact of COVID-19 on mental illness in vaccinated and unvaccinated people
- Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic
- Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic
- Interpreting pathology test result values with comparators (<, >) in Electronic Health Records research
- Antibiotics for Common Infections in Primary Care Before, During and after the COVID-19 Pandemic and Extent of Risk-Based Prescribing: Need for Personalised Guidelines
- The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in England
- Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home
- Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England
- Challenges in Estimating the Effectiveness of 2 Doses of COVID-19 Vaccine Beyond 6 Months in England
- Gout incidence and management during the COVID-19 pandemic in England, UK
- Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway
- Living alone and mental health: parallel analyses in UK longitudinal population surveys and electronic health records prior to and during the COVID-19 pandemic
- Impact of COVID-19 on recorded blood pressure screening and hypertension management in England
- Eleven key measures for monitoring general practice clinical activity during COVID-19
- Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections
- Repeated antibiotic exposure and risk of hospitalisation and death following COVID-19 infection
- Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England
- Patient Characteristics Associated with Repeat Antibiotic Prescribing Pre- and during the COVID-19 Pandemic
- A National Audit of Pancreatic Enzyme Prescribing in Pancreatic Cancer from 2015 to 2023 in England
- Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY
- Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages
- Impact of COVID-19 on broad-spectrum antibiotic prescribing for common infections in primary care in England
- The impact of COVID-19 on antibiotic prescribing in primary care in England
- Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data
- Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022
- Postoperative mortality and complications in patients with and without pre-operative SARS-CoV-2 infection
- Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England
- First dose COVID-19 vaccine coverage amongst adolescents and children in England
- Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings
- OpenSAFELY NHS Service Restoration Observatory 2
- Factors associated with COVID-19 vaccine uptake in people with kidney disease
- Primary care coding activity related to the use of online consultation systems or remote consulting
- Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease
- Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community
- Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic
- Recording of ‘COVID-19 vaccine declined’
- Association between household composition and severe COVID-19 outcomes in older people by ethnicity
- Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose
- Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England
- Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England
- Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England
- Association between oral anticoagulants and COVID-19-related outcomes
- Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies
- Safety of COVID-19 vaccination and acute neurological events
- Accident and emergency (AE) attendance in England following infection with SARS-CoV-2 Omicron or Delta
- Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England
- Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform
- Potentially inappropriate prescribing of DOACs to people with mechanical heart valves
- Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation
- Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic
- OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19
- Trends and clinical characteristics of COVID-19 vaccine recipients
- Impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic
- Clinical coding of long COVID in English primary care
- Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants
- Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
- Risks of covid-19 hospital admission and death for people with learning disability
- Factors associated with deaths due to COVID-19 versus other causes
- Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England
- Identifying Care Home Residents in Electronic Health Records
- Association between living with children and outcomes from covid-19
- Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7
- Changes in the rate of cardiometabolic and pulmonary events during the COVID-19 pandemic
- Short report: Ethnicity and COVID-19 death in the early part of the COVID-19 second wave in England
- Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19
- HIV infection and COVID-19 death
- Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality
- Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform
- Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids
- Factors associated with COVID-19-related death using OpenSAFELY